Robert Langer to open doors for young biotech company: "But ultimately people need to be convinced by the idea and the data"
With Robert Langer on board, Hervolution will have a huge network of professionals to benefit from, and the renowned scientist’s reputation will increase investor interest, according to the analysis.
It was great news to Danish biotech company Hervolution Therapeutics when it recently announced that well-known scientist Robert Langer will now chair the company’s scientific advisory board.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
